American Manganese Inc. (TSXV:AMY)(OTCQB:AMYZF)(FSE:2AM) ("AMY" or the "Company"), a pioneer in advanced and environmentally friendly lithium-ion battery cathode recycling-upcycling, is pleased to provide an update on its technology and partnership development strategy
American Manganese has produced and delivered NMC-811 (nickel manganese cobalt oxide) cathode precursor material samples to its active third-party collaborators in North America, Europe, and Asia. The feedstock material for the cathode precursor was black mass originating from waste electric vehicle batteries.
The cathode precursor is a high-value and specifically engineered material that commonly contains nickel, cobalt, and manganese, which turns into a cathode with the addition of lithium. The cathode precursor material will be independently analyzed and built into battery cells to benchmark against cathode precursors from virgin mined materials. AMY's internal analysis indicates that the cathode precursor specifications are within desired industry ranges.
"We are maintaining an active collaboration with players in the growing battery industry with our continuous lab-scale research, while we work in parallel to prepare our demonstration plant for scaled-up and continuous operation," said Larry Reaugh, President and CEO of American Manganese. "We believe our lithium-ion battery recycling and upcycling technology enables a circular solution for the battery supply chain, and we aim to strengthen our relationship with the various collaborators."
NMC-811 Precursor Cathode Active Material from Recycled Battery Waste
American Manganese Inc. is a critical metals company focused on recycling and upcycling lithium-ion battery waste into high-value battery cathode materials, using its closed-loop RecycLiCo™ process. With minimal processing steps and over 99% extraction of lithium, cobalt, nickel, and manganese, the upcycling process creates valuable lithium-ion battery materials for direct integration into the re-manufacturing of new lithium-ion batteries.
American Manganese Inc. Larry W. Reaugh President and Chief Executive Officer Telephone: 778 574 4444 Email: lreaugh@amymn.com
www.americanmanganeseinc.com www.recyclico.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release may contain "forward-looking statements", which are statements about the future based on current expectations or beliefs. For this purpose, statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements by their nature involve risks and uncertainties, and there can be no assurance that such statements will prove to be accurate or true. Investors should not place undue reliance on forward-looking statements. The Company does not undertake any obligation to update forward-looking statements except as required by law.
News Provided by ACCESSWIRE via QuoteMedia
It’s no secret that lithium-ion batteries power the modern world, and all signs point to them being an absolute necessity for future technology. The global market for lithium-ion batteries is anticipated to register a CAGR of 20.1 percent between 2021-2026, resulting in a market size of US$168 billion in 2026, a substantial increase from US$46.8 billion in 2019. The stationary energy storage market is expected to drive the market growth, with applications reaching across many industries, from telecoms to solar power generation systems. Lithium-ion batteries are so important to the future that US President Biden issued an executive order declaring a list of metals that are critical to the United States, signaling the vital importance of these metals.
Scientists and engineers around the world are racing towards the development of various lithium-ion battery recycling techniques. The projected surge in demand for these batteries creates an accompanying surge in batteries that need to be recycled 5-8 years later. Much of the research into recycling lithium-ion batteries focuses on reclaiming batteries and giving them second-life applications. However, there are other opportunities to create profitable upcycling processes that make use of production scrap and other waste materials. These recycling and upcycling processes focus on extracting valuable materials from lithium-ion batteries that can be directly used in the production of new batteries.
American Manganese Inc. (TSXV:AMY,OTCQB:AMYZF,FSE:2AM) is a technology and critical metals-driven company that is focused on advanced lithium-ion battery upcycling. The company owns two patents (US Patent No. 10,246,343 and US Patent No. 10,308,523) that power its innovative upcycling process. It also owns patents for this process in Japan and Korea. This closed-loop process takes battery manufacturing waste and end-of-life batteries and upcycles them into a high-value cathode precursor material. The company also has three mining projects located in the United States and Canada.
Lithium-ion batteries are a 31 percent active cathode material, which is a combination of lithium, nickel, manganese and cobalt. For example, modern cathodes such as lithium nickel manganese cobalt oxide and lithium nickel cobalt aluminum oxide are used in electric vehicles today. The cost of the active cathode material represents 25 percent of the total costs of lithium-ion batteries. This makes the active cathode material an important aspect of lithium-ion battery manufacturing. American Manganese has pioneered a process, called RecycLiCo, that takes battery cathode production waste and black mass from end-of-life batteries and upcycles it into high value cathode precursor material that can be directly integrated into the battery manufacturing process.
RecycLiCo is the company’s flagship project and a clear indicator of the renewed direction of the company. While American Manganese began as a mining company, they’ve since pivoted to developing and commercializing its patented upcycling process. The process is focused on “black mass” a dark substance that’s created by mechanical size reduction of end-of-life batteries and battery production wastes. Black mass is used in the RecycLiCo process to recover 99 percent of lithium, cobalt, nickel and manganese, which is astounding compared to the alternative which recovers no lithium and only 40-60 percent of nickel and cobalt.
“Generally, you can mechanically break down a battery into its individual components but we differentiate [between recycling and upcycling] by creating a higher-value product. That’s exactly what we’re doing with the production of the cathode precursor. We highlight the importance of reducing the amount of steps and going directly into a higher-value product,” said Zarko Meseldzija, chief technology officer, in a recent interview.
The current roadmap for the RecycLiCo process is to grow the project from a pilot plant and R&D into a demonstration plant. The company has committed $2.7 million towards the construction and testing of its demonstration plant which plans to further de-risk the process scale-up. Assuming the success of a demonstration plant, the next step is to create a commercial plant, which will cost an estimated $15-20 million. At this time, the company will explore licensing and joint development partnerships to further expand. In October 2021, American Manganese closed a $20 million financing with institutional investors to go towards its road to commercialization.
The RecycLiCo™ Patented Process: Innovative Lithium-ion Battery Recycling
RecycLiCo is a patented process for the upcycling of lithium-ion battery black mass and scrap materials. Black mass is created by mechanical size reduction of end-of-life lithium-ion batteries that contains valuable and critical materials such as lithium, nickel, manganese, and cobalt.
The RecycLiCo process extracts over 99% of lithium, cobalt, nickel and manganese from lithium-ion battery cathode materials. It is planned to directly integrate the upcycled materials into the re-manufacturing of lithium-ion batteries in gigafactories located around the world.
The existing alternative to RecycLiCo’s process is smelting. This process generates 2 tonnes of CO2 per tonne of metal, making it environmentally unsound. From a strictly financial perspective, smelting only recovers about 40-60% of the nickel and cobalt in lithium-ion batteries and does not recover any lithium. There are also specific additional steps and further refining that must take place before a usable product is created.
The RecycLiCo process is patented in the United States, Japan and Korea. American Manganese has already proven that their process works in a pilot plant. The next phase of the operation is to build a demonstration plant with a 500 kilogram/day capacity of lithium-ion battery cathode scrap material. Once this demonstration plant has fully illustrated the economic feasibility of the process, the next step is to develop a commercial plant capable of processing 5 tonnes/day.
In October 2020, the United States Defense Logistics Agency (DLA) awarded American Manganese a grant to perform lab-scale work on the United States Government’s manganese ore stockpile located near Wenden, Arizona, with the goal of confirming the viability of using the Company’s patented hydrometallurgical process to produce electrolytic manganese metal (EMM) from the stockpile.
Manganese is listed by the U.S. Government as a critical mineral, one of 14 minerals or metals for which the U.S. is 100% import dependent. EMM is on the acquisition list for the U.S. National Defense Stockpile. The global manganese market is greater than 41 billion pounds per year, with manganese the world’s fourth most-traded metal. There is no substitute for manganese in the production of steel.
Larry Reaugh has 55+ years’ experience in the mining industry and for the past thirty-seven years he has been the CEO and President of several exploration, development and production companies including 12 years in internet and technology breakthroughs listed on the TSX, TSX Venture and NASDAQ exchanges. Several of his companies have made significant discoveries, three of which (gold/silver) went on to be producing mines. Reaugh founded American Manganese Inc. in 1998 and has served as its President and CEO since that time. Through his career, Mr. Reaugh has raised in excess of $300 million.
Shaheem Ali is a finance and business management professional with 10 years’ experience in operations management, full cycle accounting, systems development and people management. Proven record of implementing financial and operational processes reducing operations costs and improved internal controls with Alderwoods Group Inc. where his experience includes governance and regulatory fund compliance with various states.
Zarko Meseldzija has a range of industry experience working with one of Canada’s largest energy companies and an innovation-driven process systems company. Meseldzija has deep insight into project management of multi-million-dollar projects and hydrometallurgical process development projects. He is also an owner of an independent consulting firm that focuses on the entire life cycle of the lithium-ion battery supply chain, including the recycling of critical materials. Meseldzija holds a BSc. in Mining Engineering from the University of Alberta and is a registered engineer with the Engineers and Geoscientists of British Columbia. He obtained his Management of Technology MBA from the Beedie School of Business with a focus on sustainability and innovation.
Teresa Piorun has been with the Reaugh Group of Companies for thirty years. Piorun is a senior corporate officer with wide-ranging responsibilities, serving as a focal point for communication with the board of directors, senior management and the company’s shareholders, and occupies a key role in the administration of critical corporate matters. She is the confidant and advisor to the CEO and other members of senior management, particularly on corporate governance affairs.
Dr. Hildebrand has been a practicing lawyer in British Columbia for over 40 years and has a doctorate in economics in addition to his law degree and Master of Science degree in mathematics. He was previously a director of AMY from 2007 to 2013.
American Manganese Inc. (TSXV:AMY)(OTCQB:AMYZF)(FSE:2AM) ("AMY" or the "Company") has rescheduled its annual general and special meeting of shareholders (the "Meeting") to July 8, 2022, at 11:00 a.m. Further details on the meeting will be contained in a new Notice of Meeting and the management information circular that will be mailed to shareholders and filed on SEDAR
American Manganese Inc. is a critical metals company focused on recycling and upcycling lithium-ion battery waste into high-value battery cathode materials, using its closed-loop RecycLiCo™ process. With minimal processing steps and over 99% extraction of lithium, cobalt, nickel, and manganese, the upcycling process creates valuable lithium-ion battery materials for direct integration into the re-manufacturing of new lithium-ion batteries.
On behalf of Management American Manganese Inc.
Larry W. Reaugh President and Chief Executive Officer Telephone: 778 574 4444 Email: Lreaugh@amymn.com
www.americanmanganeseinc.com www.recyclico.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release. This news release may contain "forward-looking statements", which are statements about the future based on current expectations or beliefs. For this purpose, statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements by their nature involve risks and uncertainties, and there can be no assurance that such statements will prove to be accurate or true. Investors should not place undue reliance on forward-looking statements. The Company does not undertake any obligation to update forward-looking statements except as required by law.
News Provided by ACCESSWIRE via QuoteMedia
American Manganese Inc. (TSXV:AMY)(OTCQB:AMYZF)(FSE:2AM) ("AMY" or the "Company") is pleased to have been selected as 1 of 15 finalists, among more than 120 companies, to meet with decision-makers of different business lines at Evonik Industries AG ("Evonik"), a leading specialty chemicals company. American Manganese will be presenting its patented lithium-ion battery recycling technology, RecycLiCo, at the upcoming Evonik Battery Solutions Day hosted by the Massachusetts Institute of Technology (MIT
Evonik, in collaboration with Blumorpho, is exploring potential collaboration and investment opportunities with organizations that demonstrate a high level of differentiation and strong value proposition across multiple battery solutions. Evonik is facilitating round table meetings on business discussions that will take place at MIT on May 4th and 5th, 2022.
"We are proud to be selected as 1 of 15 finalists focused on battery solutions, and we are told that American Manganese's application has raised high interest from multiple teams within Evonik," said Larry Reaugh, President and CEO of American Manganese Inc. "We will look to meet and generate high-value synergies between our RecycLiCo technology and Evonik's innovation activities and investment opportunities."
Evonik Industries AG is a chemicals company headquartered in Essen, North Rhine-Westphalia, Germany. It is the second-largest chemicals company in Germany, and one of the largest specialty chemicals companies in the world. Evonik is also a founder member of the Together for Sustainability initiative, which focuses in promoting sustainability practices across the chemical industry's supply chains.
American Manganese Inc. is a critical metals company focused on recycling and upcycling lithium-ion battery waste into high-value battery cathode materials, using its closed-loop RecycLiCo™ process. With minimal processing steps and up to 99% extraction of lithium, cobalt, nickel, and manganese, the upcycling process creates valuable lithium-ion battery materials for direct integration into the re-manufacturing of new lithium-ion batteries.
American Manganese Inc. Larry W. Reaugh, President and Chief Executive Officer Phone: 778-574-4444 Email: Lreaugh@amymn.com
www.americanmanganeseinc.com www.recyclico.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release may contain "forward-looking statements", which are statements about the future based on current expectations or beliefs. For this purpose, statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements by their nature involve risks and uncertainties, and there can be no assurance that such statements will prove to be accurate or true. Investors should not place undue reliance on forward-looking statements. The Company does not undertake any obligation to update forward-looking statements except as required by law.
News Provided by ACCESSWIRE via QuoteMedia
(This release corrects and replaces the release distributed March 29, 2022 at 6:20 pm ET. The previous release was missing the seventh paragraph and is corrected below.)
American Manganese receives Drill Permits for Rocher Deboule from Ministry of Energy, Mines and Low Carbon Innovation
American Manganese Inc. ("AMY" or the "Company") (TSXV:AMY)(OTCQB:AMYZF)(FSE:2AM) reports Vent Zone IP Geophysics Identifies High Chargeability and coincident and Significant Rare Earth Values on Rocher Deboule Cu-Au-AgProject
The Vent Zone alteration consists of chlorite-quartz-carbonate-garnet-clay hosted in and esiticflows/tuffs (porphyritic) of Upper Cretaceous Kasalka Group Brian Boru Formation. SGH (spatiotemporal geochemical hydrocarbon) surveys carried out in 2017 resulted in redox cell (6.0 out of 6.0 rating), and copper-gold anomalous zones (5.0 out of 6.0 rating) that coincide with the redox cell anomaly.In 2021, pole-dipole array IP Geophysics on "Vent Zone" target identified elevated chargeability (>30mV/V), which correlates with the redox-cell soil hydrocarbon anomaly. Widespread, disseminated sulphides (mostly fine grain pyrite) are present in the portions of the Vent Zone. IP survey high chargeability and coincident low resistivity on west portion of grid area are interpreted extent of Vent Zone. In the central part of the IP survey area, relatively strong chargeability and low resistivity increases at depths of approximately 100-200 meters (328-656 feet). The Vent Zone has positive Cu- Au-Ag-Co-REE soil geochemical anomalies and is interpreted as an Iron-Oxide Copper-Gold (IOCG) occurrence.
A total of 5 rock chip samples (ranging from 0.55-1.44 kgs in weight) were taken from outcrop (sampled intervals ranging from 15-35 centimeters) near the Rocher Mine area (proposed drilling of "Main Zone" No 4 & 3 Veins) and shipped to ALS Canada Ltd for ME-MS61r four acid multi-element ICP-MS + REE, and AuICP21Au 30-gram Fire Assay ICP-AES finish (certificate VA 21172433). The following significant results are listed:
Rock chip sample geochemical analysis results indicate massive and semi-massive chalcopyrite-pyrite mineralization (with minor bornite and molybdenite) contain significant rare earth elements (REE elements Ce- La-Nd-Pr are listed above). The Rocher Mine No 2 & 4 Veins are considered primarily as vein type (tabular shaped)copper resources accompanied by silver, gold and rare earth element bearing minerals. The distribution of rare earth elements (La-Ce-Sc-Y-Pr-Nd-Pm-Sm-Eu-Gd-Tb-Dy-Ho-Er-Tm-Yb-Lu) are associated with silicified fault zones that have magnetite and massive sulphide.Sulphides & REE do not correlate well. It is unclear whetherrare earth bearing minerals are associated with sulphide minerals or re-distributed (re-mobilized) from earlier geological (e.g., pegmatitic phase) events, or a combination of both. Rare earth elements weakly correlate with increased P, and U/Th. Note- U values ranging between 1.1-19.7 ppm uranium and Th values ranging between 0.12-13.9 ppm thorium are well below threshold values of 100 ppm U.
The two main deposit types are observed at the Rocher Mine No 4 & 2 Veins:
A drill program is planned on the Rocher Mine 2 & 4 Veins and Vent Zones for 2022.
"The BC Mineral Permit application has been laborious to complete, but is another potential catalyst for advancing the company's agenda in critical metals, such as rare earths and copper," said Larry Reaugh, President and CEO of American Manganese. "This does not take away any of the focus on the company's lithium-ion battery recycling technology, RecycLiCo."
Andris Kikauka (P. Geo.), Director for American Manganese Inc, has prepared, reviewed, and approved technical information in this press release. Mr. Kikauka is a non-independent Qualified Person adhering to National Instrument 43-101 reporting standards.
On behalf of Management American Manganese Inc.
Larry W. Reaugh President and Chief Executive Officer Telephone: 778 574 4444 Email:reaugh@amymn.com
www.americanmanganeseinc.com www.recyclico.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.This news release may contain "forward-looking statements", which are statements about the future based on current expectations or beliefs. For this purpose,statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements by their nature involve risks and uncertainties, and there can be no assurance that such statements will prove to be accurate or true. Investors should not place undue reliance on forward-looking statements. The Company does not undertake any obligation to update forward-looking statements except as required by law.
News Provided by ACCESSWIRE via QuoteMedia
American Manganese Inc. (TSXV:AMY)(OTCQB:AMYZF)(FSE:2AM) ("AMY" or the "Company"), a pioneer in advanced lithium-ion battery cathode recycling-upcycling, and its independent R&D contractor Kemetco Research Inc. ("Kemetco") are pleased to report that the equipment in the Company's demonstration plant is ready for commissioning. The plant is designed to demonstrate the RecycLiCo process in continuous operating conditions that will enable American Manganese to run the complete process and provide input for commercial operation
"The demonstration plant project is a pivotal and defining moment that will demonstrate the RecycLiCo process' ability to operate at real-world operating conditions and provide actionable feedback towards the design and development of commercial lithium-ion battery recycling-upcycling plants," said Larry Reaugh, President and CEO of American Manganese. "We will be working with third parties to validate the demonstration plant's operating efficiencies and qualify large quantities of recycled-upcycled material to aid in the progression of strategic partnerships."
The Company has received cathode scrap feedstock, with an NMC (lithium-nickel-manganese-cobalt oxide) chemistry, which is used in the latest generation electric vehicles. Once commissioned, the initial testing and operation of the demonstration plant system will commence with mechanical shredding of the cathode scrap and characterization of the feed material for hydrometallurgical processing. The hydrometallurgical processing is scheduled to run continuously while simultaneously measuring data points to monitor and collect process efficiencies. The demonstration plant will include the following core unit operations at the planned cathode scrap processing capacity of 500 kg/day:
After the initial demonstration plant program, AMY intends to continue additional operation testing of unit operations to produce upcycled materials for interested third parties. These unit operations will include the production of precursor cathode active material, lithium hydroxide, and lithium sulfate products to the desired specifications for lithium-ion battery re-manufacturing.
The global push for sustainability, rising fossil fuel prices, and supply chain instability have significantly influenced the demand and supply trends for battery metals such as lithium, nickel, cobalt, and manganese. AMY continues to advance commercialization of its intellectual property to provide a sustainable supply of these critical materials.
American Manganese Inc. is a critical metals company focused on recycling and upcycling lithium-ion battery waste into high-value battery cathode materials, using its closed-loop RecycLiCo™ process. With minimal processing steps and over 99% extraction of lithium, cobalt, nickel, and manganese, the upcycling process creates valuable lithium-ion battery materials for direct integration into the re-manufacturing of new lithium-ion batteries.
Kemetco Research is a private sector integrated science, technology, and innovation company. Their Contract Sciences operation provides laboratory analysis and testing, field work, bench scale studies, pilot plant investigations, consulting services, applied research and development for both industry and government. Their clients range from start-up companies developing new technologies through to large multinational corporations with proven processes.
Kemetco provides scientific expertise in the fields of Specialty Analytical Chemistry, Chemical Process and Extractive Metallurgy. Because Kemetco carries out research in many different fields, it can offer a broader range of backgrounds and expertise than most laboratories.
On behalf of Management American Manganese Inc.
Larry W. Reaugh President and Chief Executive Officer Telephone: 778 574 4444 Email: lreaugh@amymn.com
www.americanmanganeseinc.com www.recyclico.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release may contain "forward-looking statements", which are statements about the future based on current expectations or beliefs. For this purpose, statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements by their nature involve risks and uncertainties, and there can be no assurance that such statements will prove to be accurate or true. Investors should not place undue reliance on forward-looking statements. The Company does not undertake any obligation to update forward-looking statements except as required by law.
News Provided by ACCESSWIRE via QuoteMedia
American Manganese Inc. (TSXV:AMY)(OTCQB:AMYZF)(FSE:2AM) ("AMY" or the "Company"), a pioneer in advanced lithium-ion battery cathode recycling-upcycling, is pleased to announce that it has signed a Memorandum of Understanding (MOU) with Zenith Chemical Corporation ("Zenith") to develop a strategic expansion plan into Asia's lithium-ion battery recycling market. Zenith is an existing producer of high purity nickel sulphate for the lithium-ion battery supply chain and aims to expand its business into battery recycling and high-value cathode precursor materials. Zenith's existing nickel processing plant in Taiwan can produce up to 45,000 tonsyear of nickel sulphate
Under the agreed-upon MOU, American Manganese plans to produce high-nickel cathode precursors, such as NMC811 and NMC9x, at the existing pilot and demonstration plant scale. Zenith would then validate the material specifications and convert the precursor material into cathode active material to test its properties in lithium-ion batteries. American Manganese and Zenith Chemical will work together to achieve the timeline and milestones that would mutually benefit AMY's patented technology and Zenith's robust supply network.
"Zenith is an existing producer of battery materials for the lithium-ion battery supply chain and their incredible supply network and market intelligence offers an intangible benefit for the RecycLiCo processes expansion into Asia's battery supply chain," said Larry Reaugh, President and CEO of American Manganese. "I'm excited for the opportunity to demonstrate the RecycLiCo process capability to produce high-nickel cathode precursor product and I'm confident in our ability to achieve the desired specifications.
American Manganese Inc. is a critical metals company focused on recycling and upcycling lithium-ion battery waste into high-value battery cathode materials, using its closed-loop RecycLiCo™ process. With minimal processing steps and over 99% extraction of lithium, cobalt, nickel, and manganese, the upcycling process creates valuable lithium-ion battery materials for direct integration into the re-manufacturing of new lithium-ion batteries.
Zenith Chemical Corporation is focused on the production of nickel based chemicals, including high purity nickel sulfate for the lithium ion battery application at two plants in Taichung, Taiwan. In addition to nickel chemicals, Zenith is also leveraging its position in the lithium battery supply chain to develop additives in anode and separator to improve performance of the battery.
On behalf of Management American Manganese Inc.
Larry W. Reaugh President and Chief Executive Officer Telephone: 778 574 4444 Email: lreaugh@amymn.com
www.americanmanganeseinc.com www.recyclico.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release may contain "forward-looking statements", which are statements about the future based on current expectations or beliefs. For this purpose, statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements by their nature involve risks and uncertainties, and there can be no assurance that such statements will prove to be accurate or true. Investors should not place undue reliance on forward-looking statements. The Company does not undertake any obligation to update forward-looking statements except as required by law.
News Provided by ACCESSWIRE via QuoteMedia
ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to announce that Concierge Medical Consultants Inc. ("Concierge") has been capitalizing on the lucrative custom care market and has been extensively growing its client base to help provide personalized healthcare to Canadians. The Company continues to grow its revenue in this vertical and looks forward to sharing Q1 revenue results from Concierge at the end of this month.
The public health care system is facing unprecedented demand with patients routinely waiting over 10 hours in an emergency department for care. In the covid era, primary care is becoming increasingly difficult to access with many doctors seeing patients virtually. Patients are turning to a more personalized formula of concierge care with no time limits, no more hurried appointments or long wait times. (Source: Dr. Jibran Sharif, MD.)
The Company can see that patient needs are not being met by the current formula and that potential for Concierge can substantially grow. The demand is increasing for medical care as hospitals are filling up and doctors become less attentive due to the volume of demand of care patients. (Source: Dr. Jibran Sharif, MD.)
"Concierge prides itself in providing immediate access to healthcare professionals with same day appointments in clinic and direct email and phone contact with a concierge doctor. The company foresees great profit to continue to build from this vertical as there is a direct need for personalized medical attention", said Lena Kozovski, CEO of the Company.
"Our vision is to create a long-lasting longitudinal relationship with one of our highly trained physicians who can see you when you need, can be accessed in real time to deal with your health care needs virtually or in person at your home or place of work. You have the personal contact with your doctor at all times. The concierge medicine space has the potential for explosive growth with US market figures expected to hit 13 billion by 2030," said Dr. Jibran Sharif, President of Concierge and Chief Medical Officer of the Company.
ScreenPro is a Screening and Medical Technology company that provides turnkey screening solutions with its proprietary medical alerting software. ScreenPro's unique access to multiple manufacturers of high-quality test kits and its strategic partnership with labs in British Columbia, Ontario and Quebec allows ScreenPro to be a full-service nationwide provider of COVID testing and breast cancer screening solutions across Canada. In addition, ScreenPro has its own medical doctor and nursing professionals with on the ground support staff and transportation, with access to high quality PPEs to ensure that clients are protected in all aspects of their testing needs.
For additional information on ScreenPro and other corporate information, please visit the Company's website at www.screenprosecurity.com
Concierge Medical Consultants is a small group of board-certified practicing emergency physicians who think that urgent care does not just happen in an ER or your doctor's office, it can happen anywhere at any time. Dr Jibran Sharif, MD, CCFP EM, RDMS, is the founder and President of Concierge Medical Consultants, he is a passionate advocate of Concierge medicine and believes that all patients should have robust, timely and personalized access to health care professionals. He earned a degree in Economics at the University of British Columbia before graduating with a medical degree and residencies in Emergency Medicine and Ultrasound at the University of Sydney, University of Saskatchewan, and the University of Calgary, respectively. He is a full time Emergency physician in the GVRD and a Clinical lecturer with the faculty of Emergency Medicine at the University of British Columbia.
For additional information, please visit Concierge's website at www.conciergemedical.ca.
For more information about the Company, please refer to the Company's profile on SEDAR at www.sedar.com.
Neither the Canadian Securities Exchange (the "CSE") nor it's Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
For further information please contact:
Lena Kozovski, CEO (647) 878-6674 Email: lena@screenprosecurity.com
Priya Atwal, Communications Manager 416-901-5611 x 204 Email: Priya@screenprosecurity.com
Certain statements contained in this news release may constitute forward‐looking information, including statements relating to expectations regarding the acquisition and business of Concierge Medical Consultants Inc. and the future development of ScreenPro's business. Forward‐looking information is often, but not always, identified by the use of words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions. Forward‐looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward‐looking information. The actual results of ScreenPro could differ materially from those anticipated in this forward‐looking information as a result of regulatory decisions, competitive factors in the industries in which ScreenPro operates, prevailing economic conditions, changes to ScreenPro's strategic growth plans, and other factors, many of which are beyond the control of ScreenPro. Management of ScreenPro believes that the expectations reflected in the forward‐looking information herein are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward‐looking information should not be unduly relied upon. Any forward‐looking information contained in this news release represents ScreenPro's expectations as of the date hereof and is subject to change after such date. ScreenPro disclaims any intention or obligation to update or revise any forward‐looking information whether as a result of new information, future events or otherwise, except as required by applicable securities legislation.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/124436
News Provided by Newsfile via QuoteMedia
The Power Play by The Market Herald has announced the release of a new interview with ScreenPro Security on their latest news
The Power Play by The Market Herald provides investors with a quick snapshot of what they need to know about the company's latest press release through exclusive insights and interviews with company executives.
ScreenPro Security (CSE:SCRN) acquires Naturevan Nutrition Ltd.
ScreenPro (SCRN) acquired all issued and outstanding shares of Naturevan for $2,200,000 in cash and ScreenPro shares. Naturevan is a provider of natural health supplements and products that are distributed online and through agents across Canada. Lena Kozovski, CEO of ScreenPro sat down with Folake Ekwubiri to discuss the news. For the full interview with Lena Kozovski and to learn more about ScreenPro Security, click here
Interviews for The Power Play by The Market Herald are released daily. To learn more about the companies featured in The Power Play or to explore our other interviews visit The Power Play by The Market Herald.
The Market Herald Canada is the leading source of authoritative breaking stock market news for self-directed investors. Our team of Canadian markets reporters, editors and technologists covers the entire listed company universe in Canada. We cover over 3,985 businesses, their people, their investors, and their customers. We write the stories that move the Canadian capital markets.
DISCLAIMER: Report Card Canada Media Ltd. ("Report Card") is a wholly-owned subsidiary of Market Herald Limited, an Australian company ("Market Herald"). Report Card is not an advisory service, and does not offer, buy, sell, or provide any other rating, analysis or opinion on the securities we discuss. We are retained and compensated by the companies that we provide information on to assist them with making information available to the public. All information available on themarketherald.ca and/or this press release should be considered as commercial advertisement and not an endorsement, offer or recommendation to buy or sell securities. Report Card is not registered with any financial or securities regulatory authority in any province or territory of Canada, will not be performing any registerable activity as defined by the applicable regulatory bodies and do not provide nor claim to provide investment advice or recommendations to any visitor of this site or readers of any content on or originating from themarketherald.ca. Market Herald and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Market Herald's affiliates. In such instances, Market Herald and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Market Herald and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize any conflict. All the information on this document and/or the website - themarketherald.ca - is published in good faith and for general information purpose only. Report Card does not make any warranties about the completeness, reliability, and accuracy of this information. Any action you take upon the information you find on this document and/or website (themarketherald.ca) is strictly at your own risk. Report Card will not be liable for any losses and/or damages in connection with the use of our website. From our website, you can visit other websites by following hyperlinks to such external sites. While we strive to provide only quality links to useful and ethical websites, we have no control over the content and nature of these sites. These links to other websites do not imply a recommendation for all the content found on these sites. Site owners and content may change without notice and may occur before we have the opportunity to remove a link which may have gone 'bad'. Please be also aware that when you leave our website, other sites may have different privacy policies and terms which are beyond our control. Please be sure to check the Privacy Policies of these sites as well as their "Terms of Service" before engaging in any business or uploading any information.
The Market Herald Charity Robertson charity.robertson@themarketherald.ca themarketherald.ca
News Provided by ACCESSWIRE via QuoteMedia
ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to announce that it has completed the acquisition of Naturevan Nutrition Ltd. ("Naturevan"), a privately-held British Columbia corporation, focused on the health and wellness industry. Naturevan has 22 natural health supplement products that are sold online and through distribution agents.
The acquisition of Naturevan provides ScreenPro an entry into the health and wellness space with immediate sales, an e-commerce team, and established sales distribution channel. Naturevan is strategic to ScreenPro as it provides immediate diversification, growth opportunities through its sales channels and online platform, and synergies with Concierge Medical as it provides product offerings to clients and future expandability of business lines.
"The Company is very pleased and excited to have Naturevan Nutrition Ltd. as part of the portfolio. This is a great compliment to our existing business operations and with the ability to sell products through e-commerce and retail, this will help us diversify our revenue streams. With high grade Canadian made supplements, we look forward to sustained business growth in the years to come," said Lena Kozovski, CEO of the Company.
The Company, Naturevan and the shareholders of Naturevan have entered into a share purchase agreement pursuant to which the Company acquired all the issued and outstanding shares of Naturevan for an aggregate purchase price of $2,200,000. The purchase price was satisfied by the issuance of an aggregate of 25,833,333 units ("Units") of the Company and $650,000 in cash. Each Unit consists of one common share of the Company issued at a deemed price of $0.06 per share, and one (1) common share purchase warrant ("Warrant"). Each warrant is exercisable to acquire one (1) common share of the Company at an exercise price of $0.07 per share for a period of two (2) years.
Naturevan has become a wholly owned operating subsidiary of the Company. The Company has appointed Lena Kozovski as director, Chief Executive Officer, and Chief Financial Officer of Naturevan following the closing of the acquisition.
Naturevan is a provider of natural health supplements and products that are distributed online and through agents across Canada. Naturevan's products are proudly made in Canada. Canada's natural health supplement market is globally recognized as having first-rate standards and guidelines. To learn more about Naturevan and its products: www.naturevan.ca.
ScreenPro is a Screening and Medical Technology company that provides turnkey screening solutions with its proprietary medical alerting software. ScreenPro's unique access to multiple manufacturers of high-quality test kits and its strategic partnership with labs in British Columbia, Ontario and Quebec allows ScreenPro to be a full-service nationwide provider of COVID testing and breast cancer screening solutions across Canada. In addition, ScreenPro has its own medical doctor and nursing professionals with on the ground support staff and transportation, with access to high quality PPEs to ensure that clients are protected in all aspects of their testing needs.
For additional information on ScreenPro and other corporate information, please visit the Company's website at: www.screenprosecurity.com.
For more information about the Company, please refer to the Company's profile on SEDAR at www.sedar.com.
Neither the Canadian Securities Exchange (the "CSE") nor it's Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
For further information please contact:
Lena Kozovski, CEO Email: investors@screenprosecurity.com Phone: 416.901.5611 ext. 204
Certain statements contained in this news release may constitute forward-looking information, including statements relating to expectations regarding the acquisition of Naturevan Nutrition Ltd., and the future development of ScreenPro's business. Forward-looking information is often, but not always, identified using words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. The actual results of ScreenPro could differ materially from those anticipated in this forward-looking information because of regulatory decisions, competitive factors in the industries in which ScreenPro operates, prevailing economic conditions, changes to ScreenPro's strategic growth plans, and other factors, many of which are beyond the control of ScreenPro. Management of ScreenPro believes that the expectations reflected in the forward-looking information herein are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking information should not be unduly relied upon. Any forward-looking information contained in this news release represents ScreenPro's expectations as of the date hereof and is subject to change after such date. ScreenPro disclaims any intention or obligation to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable securities legislation.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/123858
News Provided by Newsfile via QuoteMedia
ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to report that the Company has administered 29,519 Covid-19 tests in April, an increase of 15% compared to March's Covid testing numbers of 25,517.
With the recent news of Toronto's mayor terminating the Covid-19 emergency declaration that was put in place at the beginning of the pandemic in March 2020 and the surge of cases with the new omicron subvariants world-wide, the Company is confident that Covid testing numbers and market share will continue to increase significantly as testing demand is growing each month within the community.
"We are pleased that our core business in Covid testing remains strong with an increase of sales in April. As infections continue to trend upwards, we foresee our testing sales to increase further. Management would also like to address the recent news of the SAG AFTRA amendment to stop testing for Zone C (office) and Zone D (postproduction). This news in the film and production industry has minimal effect on our Covid testing business as majority of the testing we administer has been and continues to be for Zone A (cast) and Zone B (crew)," said Lena Kozovski, CEO of the Company.
ScreenPro is a Screening and Medical Technology company that provides turnkey screening solutions with its proprietary medical alerting software. ScreenPro's unique access to multiple manufacturers of high-quality test kits and its strategic partnership with labs in British Columbia, Ontario and Quebec allows ScreenPro to be a full-service nationwide provider of COVID testing and breast cancer screening solutions across Canada. In addition, ScreenPro has its own medical doctor and nursing professionals with on the ground support staff and transportation, with access to high quality PPEs to ensure that clients are protected in all aspects of their testing needs.
For additional information on ScreenPro and other corporate information, please visit the Company's website at www.screenprosecurity.com.
For more information about the Company, please refer to the Company's profile on SEDAR at www.sedar.com.
Neither the Canadian Securities Exchange (the "CSE") nor it's Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
For further information please contact:
Lena Kozovski, CEO Email: investors@screenprosecurity.com
Certain statements contained in this news release may constitute forward‐looking information, including statements relating to expectations regarding the acquisition and business of Concierge Medical Consultants Inc. and the future development of ScreenPro's business. Forward‐looking information is often, but not always, identified by the use of words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions. Forward‐looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward‐looking information. The actual results of ScreenPro could differ materially from those anticipated in this forward‐looking information as a result of regulatory decisions, competitive factors in the industries in which ScreenPro operates, prevailing economic conditions, changes to ScreenPro's strategic growth plans, and other factors, many of which are beyond the control of ScreenPro. Management of ScreenPro believes that the expectations reflected in the forward‐looking information herein are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward‐looking information should not be unduly relied upon. Any forward‐looking information contained in this news release represents ScreenPro's expectations as of the date hereof and is subject to change after such date. ScreenPro disclaims any intention or obligation to update or revise any forward‐looking information whether as a result of new information, future events or otherwise, except as required by applicable securities legislation.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/123314
News Provided by Newsfile via QuoteMedia
ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to report that the Company has reported over $21 million of revenue. The Company filed on SEDAR its financial statements ("FS") and related management discussion and analysis ("MD&A") for the year end results ending December 31, 2021 ("Q4 2021").
The Company reported revenue of over $21 million, net income of ($10 million), EBITDA of ($8.2 million), and Adjusted EBITDA of ($1.7 million). Total operating expenses for the period ended December 31, 2021, was $6.5 million, largely due to professional fees related to various legal and accounting activities for the Reverse Take Over (RTO), and an acquisition completed during the period. The Company also recorded a non-cash depreciation cost of $2 million related to the Company's equipment, right-of-use asset and intangible assets acquired during the period. Another significant item to note is the listing expense of $1.7 million relating to the RTO representing ScreenPro's costs to obtain a listing on the CSE. The Company's decreased cash flow of ($238,288) was due to the Company's investment of purchasing $1.6 million worth of Covid-19 test inventory and $797,148 of lab property and equipment for operations to further advance business and profit.
"The Company has built a strong and successful foundation for Covid testing. Prominent film and production companies throughout Canada trust ScreenPro to keep them safe while working throughout the pandemic. As the need for Covid testing increases this year, we look forward to focusing on not only accelerating our testing services but also diversifying the Company into other health screening products that will be just as profitable as Covid testing," said Lena Kozovski, CEO of the Company.
"We have continued our momentum of our core business and have entered 2022 with strong Covid testing numbers. We are proud of our team in achieving record revenues from Covid Testing resulting in revenues of over $21 million. The company is focused on alignment with our shareholders to maximize shareholder value and continue to be opportunistic and expand our product offerings in 2022," said Michael Yeung, Chairman of the Company.
The following is selected financial information for financial results ending December 31, 2021. Please refer to the Q4 2021 filing in its entirety, which is available under ScreenPro's profile at www.sedar.com.
Financial Highlights for thirteen months, financial results ended December 31, 2021:
The following table summarizes revenue, net loss, and EBITDA* and adjusted EBITDA* for the year ended December 31, 2021, and 2020. All figures are in Canadian dollars unless otherwise noted:
The Company's financial performance greatly improved in the third and fourth quarter, attributed by growth due to its core business in Covid testing. Testing continues to have strong demand, which further improves the Company's financial position. From December 2021 to March 2022, the Company has administered approximately 82,636 Covid tests. In the first quarter of 2022, ScreenPro achieved continued growth in its testing numbers.
Testing numbers are as follows:
Due to the Company's focus in the film industry, strong testing revenue is expected in 2022 as the Company does not foresee change in processes in the near term in the film industry. ScreenPro recently announced that as of April 8, 2022, the company has been awarded a total of 21 new productions to date for Q1 of FY22. As Canadian's face a surge of COVID-19 cases, the Company remains focused in 2022 to capitalize further on testing services as there is an increased demand for testing in the film and production industry and in the community.
The Company continues to diversify their product and service offerings and expects to see significant growth as they expand further into the health screening space with the acquisition of Add Biomedical ("Add Bio") and potentially other future opportunities. Add Bio has recently submitted applications to the Canadian Intellectual Property Office (CIPO) and United states Patent and Trademark Office (USPTO) and plans to enter the breast cancer testing industry.
The Board of Directors has mandated management of ScreenPro to continue to focus on growth of revenue and improve its profitability in 2022 via diversification of products and services. Strategies to achieve the objectives would include organic growth of its subsidiaries, acquisitions, mergers, or joint ventures of companies that are synergistic and have potential value for ScreenPro. The Company anticipates an exciting 2022 filled with activity from its operational and corporate objectives, particularly growth of its Covid testing and expansion into other screening products and services that will be profitable and add to the Company's value.
ScreenPro is a Screening and Medical Technology company that provides turnkey screening solutions with its proprietary medical alerting software. ScreenPro's unique access to multiple manufacturers of high-quality test kits and its strategic partnership with labs in British Columbia, Ontario and Quebec allows ScreenPro to be a full-service nationwide provider of COVID testing and breast cancer screening solutions across Canada. In addition, ScreenPro has its own medical doctor and nursing professionals with on the ground support staff and transportation, with access to high quality PPEs to ensure that clients are protected in all aspects of their testing needs.
For additional information on ScreenPro and other corporate information, please visit the Company's website at www.screenprosecurity.com
For more information about the Company, please refer to the Company's profile on SEDAR at www.sedar.com.
Neither the Canadian Securities Exchange (the "CSE") nor it's Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
For further information please contact:
Lena Kozovski, CEO Email: investors@screenprosecurity.com
Certain statements contained in this news release may constitute forward‐looking information, including statements relating to expectations regarding the acquisition and business of Concierge Medical Consultants Inc. and the future development of ScreenPro's business. Forward‐looking information is often, but not always, identified by the use of words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions. Forward‐looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward‐looking information. The actual results of ScreenPro could differ materially from those anticipated in this forward‐looking information as a result of regulatory decisions, competitive factors in the industries in which ScreenPro operates, prevailing economic conditions, changes to ScreenPro's strategic growth plans, and other factors, many of which are beyond the control of ScreenPro. Management of ScreenPro believes that the expectations reflected in the forward‐looking information herein are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward‐looking information should not be unduly relied upon. Any forward‐looking information contained in this news release represents ScreenPro's expectations as of the date hereof and is subject to change after such date. ScreenPro disclaims any intention or obligation to update or revise any forward‐looking information whether as a result of new information, future events or otherwise, except as required by applicable securities legislation.
The Company has included non-IFRS performance measures throughout this press release, including (a) Earnings Before Interest, Taxes, Depreciation and Amortization ("EBITDA"); (b) Adjusted EBITDA which is EBITDA adjusted for the gain (loss) on change in fair value of the Company's investment properties and the gain (loss) on change in fair value of derivative instruments; and (c) Book Value per Share which is calculated as equity attributable to Datametrex AI Limited shareholders divided by total common shares outstanding at the end of the reporting period. These non-IFRS financial measurements do not have any standardized meaning as prescribed by International Financial Reporting Standards ("IFRS") and are therefore unlikely to be comparable to similar measures presented by other issuers. Accordingly, these performance measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS. Management uses EBITDA metrics to measure the profit trends of the business units and segments in the consolidated group since it eliminates the effects of financing decisions. Certain investors, analysts and others utilize these non-IFRS financial metrics in assessing the Company's financial performance. These non-IFRS financial measurements have not been presented as an alternative to net income or any other financial measure of performance prescribed by IFRS. Reconciliation of non-IFRS measures has been provided throughout the Company's MD&A, as applicable, filed under the Company's profile on www.SEDAR.COM.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/122456
News Provided by Newsfile via QuoteMedia
ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to report a significant increase in the Covid-19 testing numbers this year, which attributes to the Company's stronger cash position. Covid testing remains in high demand for the film and production industry. Due to the nature of the work environment, staff members are often operating in contained areas and in close proximity. With various highly contagious variants, such as Omicron and the numbers of infections increasing, we foresee more contracts throughout 2022.
The Company also faces a rise in demand for testing in the travel and tourism industry along with its concierge (home/office visit) services. In addition to the news release on March 24th, 2022, the Company has received three additional testing contracts in television and production dated as of April 8, 2022, resulting in a total of 21 new productions to date for Q1 of FY22.
Recent testing numbers are as follows:
"As Canada faces a spike in Covid-19 cases and a possible sixth wave, the Company continues to build momentum with the Covid testing business for the film and production industry. We have also increased our testing services in the travel industry to meet potential demand as more and more people are travelling internationally," said Michael Yeung, Chairman of the Company.
"The film industry is still feeling the strain of the pandemic and have to continuously turn to Covid testing to keep individuals safe whilst on set. As the need for Covid testing expands, and as more people travel, we are confident that our testing continues to yield great revenue and profitability. We also anticipate securing more contracts which will attribute to higher revenue and profit for our shareholders," said Lena Kozovski, CEO of the Company.
ScreenPro is a Screening and Medical Technology company that provides turnkey screening solutions with its proprietary medical alerting software. ScreenPro's unique access to multiple manufacturers of high-quality test kits and its strategic partnership with labs in British Columbia, Ontario and Quebec allows ScreenPro to be a full-service nationwide provider of COVID testing and breast cancer screening solutions across Canada. In addition, ScreenPro has its own medical doctor and nursing professionals with on the ground support staff and transportation, with access to high quality PPEs to ensure that clients are protected in all aspects of their testing needs.
For additional information on ScreenPro and other corporate information, please visit the Company's website at www.screenprosecurity.com.
For more information about the Company, please refer to the Company's profile on SEDAR at www.sedar.com.
Neither the Canadian Securities Exchange (the "CSE") nor it's Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
For further information please contact:
Lena Kozovski, CEO Email: investors@screenprosecurity.com
Certain statements contained in this news release may constitute forward‐looking information, including statements relating to expectations regarding the acquisition and business of Concierge Medical Consultants Inc. and the future development of ScreenPro's business. Forward‐looking information is often, but not always, identified by the use of words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions. Forward‐looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward‐looking information. The actual results of ScreenPro could differ materially from those anticipated in this forward‐looking information as a result of regulatory decisions, competitive factors in the industries in which ScreenPro operates, prevailing economic conditions, changes to ScreenPro's strategic growth plans, and other factors, many of which are beyond the control of ScreenPro. Management of ScreenPro believes that the expectations reflected in the forward‐looking information herein are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward‐looking information should not be unduly relied upon. Any forward‐looking information contained in this news release represents ScreenPro's expectations as of the date hereof and is subject to change after such date. ScreenPro disclaims any intention or obligation to update or revise any forward‐looking information whether as a result of new information, future events or otherwise, except as required by applicable securities legislation.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/120120
News Provided by Newsfile via QuoteMedia
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.